References
- Al-Mugahed L. (2008) Khat chewing in Yemen: turning over a new leaf, Bulletin of the World Health Organization 86(10), 741–742.
- Alock C. (2010) Can I get high legally (documentary film). BBC Three.
- Angoa-Pérez M., Kane M. J., Francescutti D. M., Sykes K. E., Shah M. M., Mohammed A. M., Thomas D. M. and Kuhn D. M. (2012) Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum, Journal of Neurochemistry 120, 1097–1107.
- BBC. (2010) Ecstasy ‘disappearing’ from British clubs (available at: http://www.bbc.co.uk/newsbeat/10353130) (accessed on 14 May 2014).
- BBC. (2014) Peer approve plans to ban Khat (available at: http://www.bbc.co.uk/democracylive/house-of-lords-27385555) (accessed 22 May 2014).
- Boire R. G. (1995) Concerning the legal status of catha edulis (khat), The Entheogen Law Reporter 7, 60–62 (available at: http://www.erowid.org/library/periodicals/journals/telr/telr_7.pdf) (accessed 20 May 2014).
- Brunt T. M., Poortman A., Niesink R. J. and Van den brink W. (2010) Instability of the ecstasy market and a new kid on the block: mephedrone, Journal of Psychopharmacology 25(11), 1543–1547.
- CNBC. (2013) Global drugs trade ‘as strong as ever’ as fight fails (available at: http://www.cnbc.com/id/100957882) (accessed on 18 April 2014).
- Cassanelli L. V. (1986) Qat: changes in the production and consumption of a quasilegal commodity in northeast Africa, in Appadurai A. (Ed) The Social Life of Things: Commodities in Cultural Perspective, pp. 236–257. Cambridge University Press, Cambridge.
- Caudevilla-Gálligo F., Riba J., Ventura M., Gonzalez D., Farre M., Barbanoj M. J. and Bouso J. C. (2012) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects, Journal of Psychopharmacology 26(7), 1026–1035.
- Corazza O., Schifano F., Farre M., Deluca P., Davey Z., Drummond C., Torrens M., Demetrovics Z., DI Furia L., Flesland L., Mervo B., Moskalewicz J., Pisarska A., Shapiro H., Siemann H., Skutle A., Pezzolesi C., Van der Kreeft P. and Scherbaum N. (2011) Designer drugs on the internet: a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly, Current Clinical Pharmacology 6(2), 125–129.
- Corva D. (2013) Requiem for a CAMP: the life and death of a domestic U.S. drug war institution, International Journal of Drug Policy 25(1), 71–80.
- DEA. (2004). DEA announces arrests of website operators selling illegal designer drugs (available at: http://www.justice.gov/dea/pubs/pressrel/pr072204.html) (accessed 11 May 2014).
- DEA. (2014) DEA news: huge synthetic drug takedown (available at: http://www.justice.gov/dea/divisions/hq/2014/hq050714.shtml) (accessed 23 May 2014).
- DEA Federal Register Entry. (1993) 21 CFR Part 1308 (available at: https://www.erowid.org/freedom/law/federal_register/58.FR.4316.shtml) (accessed 20 May 22, 2014).
- Dybdal-Hargreaves N. F., Holder N. D., Ottoson P. E., Sweeney M. D. and Williams T. (2013) Mephedrone: public health risk, mechanisms of action, and behavioral effects, European Journal of Pharmacology 714(1–3), 32–40.
- Erowid. (2014a) What does ‘molly’ mean in reference to MDMA? (Question ID: 1793), ask Erowid (available at: http://www.erowid.org/ask/ask.php?ID=1793) (accessed on 17 May 2014).
- Erowid. (2014b) bk-MBDB legal status (available at: https://www.erowid.org/chemicals/bk_mbdb/bk_mbdb_law.shtml) (accessed on 17 May 2014).
- Escohotado A. (2010) The General History of Drugs, Vol. I. Graffiti Militante Press, Valparaiso.
- Feinstein D. (2013) Press release: Feinstein introduces bill to combat dangerous synthetic drugs (available at: http://www.feinstein.senate.gov/public/index.cfm/press-releases?ID=2ffa01a7-a73c-4016-aec7-07da34d9f230) (accessed on 23 May 2014).
- Freeman T. P., Morgan C. J. A., Vaughn-Jones J., Hussain N., Karimi K. and Curran H. V. (2012) Cognitive and subjective effects of mephedrone and factors influencing use of a ‘new legal high’, Addiction 107(4), 792–800.
- German C. L., Fleckenstein A. E. and Hanson G. R. (2014) Bath salts and synthetic cathinones: an emerging designer drug phenomenon, Life Sciences 97(1), 2–8.
- Gray J. (2010) Mephedrone: the new nightclub drug. Details. (available at: http://www.details.com/culture-trends/critical-eye/201008/plant-food-drug-mephedrone-mcat-meow-meow) (accessed 23 May 2014).
- Herbal∼Jah. (2011) View full version: (RC's) 4-bromomethcathinone (brephedrone), Bluelight.org, p. 1 (available at: http://www.bluelight.org/vb/archive/index.php/t-576507.html) (accessed on 22 May 2014).
- Heyman J. McC (2013) The study of illegality and legality: which way forward? PoLAR: Political and Legal Anthropology Review 2(36), 304–307.
- Holland J. (2001) Ecstasy: The Complete Guide. Park St. Press, Rochester, NY.
- Jenkins P. (1999) Synthetic Panics: The Symbolic Politics of Designer Drugs. New York University Press, New York City, NY.
- Johnson L. A., Johnson R. L. and Portier R-B. (2013) Current ‘legal highs’, The Journal of Emergency Medicine 44(6), 1108–1115.
- Kau G. (2008) Flashback to the Federal Analog Act of 1986: mixing rules and standards in the cauldron, University of Pennsylvania Law Review 156(4), 1077–1115.
- Kelly B. C., Wells B. E., Pawson M., Leclair A., Parsons J. T. and Golub S. A. (2013) Novel psychoactive drug use among younger adults involved in US nightlife scenes, Drug and Alcohol Review 32(6), 588–593.
- Kirsch I. (2010) The Emperor's New Drugs: Exploding the Antidepressant Myth. Basic Books, New York, NY.
- Koebler J. (2012) Miami's ‘naked zombie’ proves need to ban bath salts, experts say, U.S. News & World Report (available at: http://www.usnews.com/news/articles/2012/05/30/miamis-naked-zombie-proves-need-to-ban-bath-salts-experts-say) (accessed on 12 May 2014).
- Madras B. (2012) Designer drugs: an escalating public health challenge, The Journal of Global Drug Policy and Practice 6(3), 1–57. (available at: http://www.globaldrugpolicy.org/Issues/Vol%206%20Issue%203/Designer%20Drugs%20FINAL%20V6%20formatted.pdf) (accessed on 22 May 2014).
- Máté K-F., Kertész M., Winstock A., Deluca P., Corazza O., Farkas J., Zacher G., Urbán R. and Demetrovics Z. (2013) Substitutional potential of mephedrone: an analysis of the subjective effects, Human Psychopharmacology: Clinical and Experimental, 28(4), 308–316.
- Mccoy A. (2004) The stimulus of prohibition: a critical history of the global narcotics trade, in Steinberg M. K., Hobbs J. J. and Mathewson K. (Eds) Dangerous Harvest: Drug Plants and the Transformation of Indigenous Landscapes, pp. 24–111. Oxford University Press, Oxford.
- Measham F., Wood D. M., Dargan P. I. and Moore K. (2011) The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation ‘legal highs’ in South London gay dance clubs, Journal of Substance Use 16(4), 263–272.
- Miotto K., Striebel J., Cho A. K. and Wang C. (2013) Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports, Drug and Alcohol Dependence 132(1–2), 1–12.
- Morris K. (2010) UK places generic ban on mephedrone drug family, The Lancet 375(9723), 1333–1334.
- Naim M. (2006) Illicit: How Smugglers, Traffickers, and Copycats are Hijacking the Global Economy. Doubleday, New York, NY.
- National Drug Intelligence Center (NDIC). (2011) Synthetic cathinones (bath salts): an emerging domestic threat. Situation Report (available at: http://www.justice.gov/archive/ndic/pubs44/44571/44571p.pdf) (accessed on 25 July 2013).
- Naylor R. T. (2002) Wages of Crime: Black Markets, Illegal Finance, and the Underworld Economy. McGill-Queen's University Press, Montreal.
- Office of U.S. Department of the Treasury. (2014) Treasury Sanctions International Synthetic Drug Trafficking Organization (available at: http://www.legistorm.com/stormfeed/view_rss/405720/organization/69540.html) (accessed 23 May 2014).
- Pine J. (2010) Embodied capitalism and the meth body, in Moore L. J. and Kosut M. (Eds) The Body Reader: Essential Social and Cultural Readings, pp. 164–183. New York University Press, New York.
- Power M. (2013) From Chinese factory to UK households – realities of the trade in legal highs. The Guardian (available at: http://www.theguardian.com/society/2013/may/09/chinese-factory-trade-legal-high) (accessed 13 May 23, 2014).
- Power M. (2014) The drug revolution that no one can stop (available at: https://medium.com/matter/19f753fb15e0) (accessed on 13 May 2014).
- Ramsey J., Dargan P. I., Smyllie M., Davies S., Button J., Holt D. W. and Wood D. M. (2010) Buying ‘legal’ recreational drugs does not mean that you are not breaking the law, QJM: An International Journal of Medicine 103(10), 777–783.
- Ryan J. (2012) Schumer blasts Rand Paul for hold on bill to ban ‘bath salts’ drugs. The Hill (available at: http://thehill.com/blogs/floor-action/senate/210919-schumer-blasts-rand-paul-for-hold-on-bill-to-ban-synthetic-drugs) (accessed on 20 May 2014).
- Scott P. D. (2010) American War Machine: The CIA Global Drug Connection, and the Road to Afghanistan. Rowman and Littlefield, New York, NY.
- Shulgin A., Manning T., and Daley P. (2011) The Shulgin Index Vol 1: Psychedelic Phenethylamines and Related Compounds. Transform Press, Berkeley, CA.
- Shulgin A. and Shulgin A. (1991) PIHKAL: A Chemical Love Story. Transform Press, Berkeley, CA.
- Shulgin A. and Shulgin A. (1997) TIHKAL: The Continuation. Transform Press, Berkeley, CA.
- Simmler L. D., Rickli A., Hoener M. C. and Liechti M. E. (2014) Monoamine transporter and receptor interaction profiles of a new series of designer cathinones, Neuropharmacology 79, 152–160.
- Smith V. (2013) Hysteria: in Maryland and across the country, the federal designer-drug crackdown takes prisoners, cash, and a legal backlash. City Paper (available at: http://citypaper.com/news/hysteria-1.1572565) (accessed 23 May 2014).
- Soodin V. (2010) Legal drug teen ripped his scrotum off. The Sun (available at: http://www.thesun.co.uk/sol/homepage/news/2747979/Meow-meow-drug-teen-ripped-his-scrotum-off.html) (accessed 23 May 2014).
- Stogner J. M. and Miller B. L. (2013) Investigating the ‘bath salt’ panic: the rarity of synthetic cathinone use among students in the United States, Drug and Alcohol Review 32(5), 545–549.
- Sweetingham L. (2009) Chemical Cowboys. Ballantine Books, New York, NY.
- Taylor J. S., Jasparro C. and Mattson K. (2013) Geographers and drugs: a survey of the literature, Geographical Review 103(3), 415–430.
- Terry S. (2014) Bath salt abuse: more than just hot water, Journal of Emergency Nursing 40(1), 88–91.
- Thomas K. and Galemba R. (2013) Illegal anthropology: an introduction, PoLAR Political and Legal Anthropology Review 36(2), 211–214.
- United Nations Statistics Division. (2014) National accounts main aggregates database (available at: http://unstats.un.org/unsd/snaama/dnltransfer.asp?fID=2) (accessed on 13 May 2014).
- USA vs. Justin Stevens Scroggins. (2012) CRIMINAL NO. 2:11cr70. Sentencing position of the United States. United States District Court for the Eastern District of Virginia.
- Van Hout M. C. and Bingham T. (2013) ‘Surfing the silk road’: a study of users’ experiences, International Journal of Drug Policy 24(6), 524–529.
- Van Hout M. C. and Brennan R. (2011) ‘Bump and grind’: an exploratory study of Mephedrone users’ perceptions of sexuality and sexual risk, Drugs and Alcohol Today 11(2), 93–103.
- Van Schendel W. and Abraham I. (2005) Illicit Flows and Criminal Things: States, Borders, and the Other Side of Globalization. Indiana University Press, Bloomington.
- Walsh C. (2011) Drugs, the Internet, and change, Journal of Psychoactive Drugs 43(1), 55–63.
- Wikipedia Contributors. (2014) Substituted cathinone, in Wikipedia, The Free Encyclopedia (available at: http://en.wikipedia.org/w/index.php?title=Substituted_cathinone&oldid=604535589) (accessed 27 May, 2014).
- Winder G., Stern N. and Hosanagar A. (2013) Are ‘Bath Salts’ the next generation of stimulant abuse? Journal of Substance Abuse Treatment 44(1), 42–45.
- Winstock A. R., Marsden J. and Mitcheson L. (2010) What should be done about mephedrone? British Medical Journal 340, c1605.
- Winstock A. R., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M. and Marsden J. (2011) Mephedrone: use, subjective effects and health risks, Addiction 106(11), 1991–1996.
- Wood D. M., Measham F. and Dargan P. I. (2012) ‘Our favorite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control, Journal of Substance Use 17(2), 91–97.